Sarcoidosis of the sinonasal tract: a new staging system.
Sarcoidosis is a chronic multisystem granulomatous disease that has a predilection for pulmonary and upper respiratory tract involvement. Because the initial signs and symptoms of sarcoidosis may be identical to those of other forms of chronic sinonasal inflammatory disease, these patients will often first seek treatment from an otolaryngologist. We present a series of 28 patients whose primary symptoms was involvement of a sinonasal tract. A new staging system is proposed to categorize the severity and sites of involvement and to guide the aggressiveness of therapy. Sarcoidosis should be considered in the differential diagnosis of inflammatory sinonasal disease.
Krespi
Y P
YP
Department of Otolaryngology/Head and Neck Surgery, St. Luke's/Roosevelt Hospital Center, New York, NY 10019.
Kuriloff
D B
DB
Aner
M
M
D000328:Adult; D001507:Beclomethasone / Q000627:therapeutic use; D002908:Chronic Disease; D003251:Constriction, Pathologic / Q000473:pathology; D003937:Diagnosis, Differential; D004487:Edema / Q000473:pathology; D004844:Epistaxis / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015508:Nasal Obstruction / Q000473:pathology; D009667:Nose Deformities, Acquired / Q000473:pathology; D009668:Nose Diseases / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D010254:Paranasal Sinus Diseases / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000267:Tissue Adhesions / Q000473:pathology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D014222:Triamcinolone Acetonide; D001507:Beclomethasone; D011241:Prednisone